Works matching IS 09024441 AND DT 2010 AND VI 84 AND IP 3
Results: 14
Vorinostat enhances the antimyeloma effects of melphalan and bortezomib.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 201, doi. 10.1111/j.1600-0609.2009.01384.x
- By:
- Publication type:
- Article
BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 229, doi. 10.1111/j.1600-0609.2009.01387.x
- By:
- Publication type:
- Article
Quality in Laboratory Hemostasis and Thrombosis.
- Published in:
- 2010
- By:
- Publication type:
- Book Review
Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype–phenotype associations.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 191, doi. 10.1111/j.1600-0609.2009.01392.x
- By:
- Publication type:
- Article
Massive intravascular haemolysis during Clostridium perfrigens sepsis of hepatic origin.
- Published in:
- 2010
- By:
- Publication type:
- Other
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Successful umbilical cord blood stem cell transplantation in a child with WHIM syndrome.
- Published in:
- 2010
- By:
- Publication type:
- Letter
DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in Multiple Myeloma.
- Published in:
- 2010
- By:
- Publication type:
- Letter
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin’s lymphoma.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 266, doi. 10.1111/j.1600-0609.2009.01375.x
- By:
- Publication type:
- Article
Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 259, doi. 10.1111/j.1600-0609.2009.01379.x
- By:
- Publication type:
- Article
Bortezomib restores stroma-mediated APO2L/TRAIL apoptosis resistance in multiple myeloma.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 212, doi. 10.1111/j.1600-0609.2009.01381.x
- By:
- Publication type:
- Article
Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 239, doi. 10.1111/j.1600-0609.2009.01382.x
- By:
- Publication type:
- Article
Antibody buffering of systemically administered lysozyme.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 252, doi. 10.1111/j.1600-0609.2009.01383.x
- By:
- Publication type:
- Article
Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 223, doi. 10.1111/j.1600-0609.2009.01385.x
- By:
- Publication type:
- Article